AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Palisade Bio, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Emil Chuang, a director of Palisade Bio, Inc. (PALI), was granted 18,800 phantom units on 09/04/2025. Each phantom unit equals one share of common stock and the units were granted at $0 per unit. The units vest in three equal annual installments beginning August 5, 2026, subject to continued service.

Vested phantom units will be settled solely in cash based on the fair market value of the equivalent number of shares upon termination of service, a defined liquidity change in control, or the seventh anniversary of the grant. The Form 4 reports 18,800 shares beneficially owned following the transaction and is signed by attorney-in-fact Ryker Willie on 09/05/2025.

Emil Chuang, amministratore di Palisade Bio, Inc. (PALI), ha ricevuto 18.800 unità fantasma il 04/09/2025. Ciascuna unità fantasma corrisponde a una azione ordinaria ed è stata assegnata a $0 per unità. Le unità maturano in tre rate annuali uguali a partire dal 5 agosto 2026, subordinatamente al proseguimento del servizio.

Le unità fantasma maturate saranno liquidate esclusivamente in contanti in base al valore di mercato delle azioni corrispondenti al momento della cessazione del servizio, di un determinato cambio di controllo con evento di liquidità, o al settimo anniversario della concessione. Il Modulo 4 riferisce 18.800 azioni possedute beneficiariamente a seguito della transazione ed è firmato dall’avvocato delegato Ryker Willie il 05/09/2025.

Emil Chuang, director de Palisade Bio, Inc. (PALI), recibió 18.800 unidades fantasma el 04/09/2025. Cada unidad fantasma equivale a una acción ordinaria y se concedieron a $0 por unidad. Las unidades consolidan en tres cuotas anuales iguales a partir del 5 de agosto de 2026, sujeto a la continuidad del servicio.

Las unidades fantasma consolidadas se liquidarán únicamente en efectivo según el valor razonable de mercado del mismo número de acciones al momento de la terminación del servicio, de un cambio de control con evento de liquidez definido, o del séptimo aniversario de la concesión. El Formulario 4 informa 18.800 acciones poseídas beneficiariamente tras la transacción y está firmado por el apoderado Ryker Willie el 05/09/2025.

파리지ë“� ë°”ì´ì˜�(Palisade Bio, Inc., PALI) ì´ì‚¬ Emil Chuangì—게 2025ë…� 9ì›� 4ì¼ì— 18,800ê°œì˜ íŒ¬í…€ 유닛ì� 부여ë˜ì—ˆìŠµë‹ˆë‹¤. ê°� 팬텀 ìœ ë‹›ì€ ë³´í†µì£� 1ì£¼ì— í•´ë‹¹í•˜ë©° 단가 $0ë¡� 부여ë˜ì—ˆìŠµë‹ˆë‹¤. 해당 ìœ ë‹›ì€ 2026ë…� 8ì›� 5ì¼ë¶€í„� 매년 ë™ì¼í•� 비율ë¡� 3íšŒì— ê±¸ì³ ë² ìŠ¤íŒ…ë˜ë©� ê³„ì† ê·¼ë¬´ë¥� 조건으로 합니ë‹�.

ë² ìŠ¤íŒ…ëœ íŒ¬í…€ ìœ ë‹›ì€ ê·¼ë¬´ 종료 ì‹�, ì •ì˜ë� 유ë™ì„� 있는 ì¸ìˆ˜í•©ë³‘(ì²´ì¸ì§€ì˜¤ë¸Œì»¨íЏë¡�) ë°œìƒ ì‹� ë˜ëŠ” 부여ì¼ë¡œë¶€í„� 7주년ì—� 해당하는 시ì ì—� ë™ë“±í•� 수량ì� 주ì‹ì� ê³µì •ì‹œìž¥ê°€ì¹˜ì— ë”°ë¼ í˜„ê¸ˆìœ¼ë¡œë§� ì •ì‚°ë©ë‹ˆë‹�. Form 4ì—는 거래 í›� 18,800ì£¼ì˜ ì‹¤ì§ˆ 소유가 ë³´ê³ ë˜ì–´ 있으ë©�, 2025ë…� 9ì›� 5ì� ëŒ€ë¦¬ì¸ Ryker Willieê°€ 서명했습니다.

Emil Chuang, administrateur de Palisade Bio, Inc. (PALI), s’est vu accorder 18 800 unités fantômes le 04/09/2025. Chaque unité fantôme équivaut à une action ordinaire et les unités ont été attribuées à 0 $ l’unité. Les unités acquièrent des droits en trois versements annuels égaux à partir du 5 août 2026, sous réserve de la poursuite du service.

Les unités fantômes acquises seront réglées uniquement en numéraire en fonction de la juste valeur marchande du nombre équivalent d’actions lors de la cessation de service, d’un changement de contrôle défini avec événement de liquidité, ou au septième anniversaire de l’octroi. Le formulaire 4 signale 18 800 actions détenues bénéficiairement suite à la transaction et est signé par le mandataire Ryker Willie le 05/09/2025.

Emil Chuang, Direktor von Palisade Bio, Inc. (PALI), erhielt am 04.09.2025 18.800 Phantom-Einheiten. Jede Phantom-Einheit entspricht einer Stammaktie und die Einheiten wurden zu $0 pro Einheit gewährt. Die Einheiten vesten in drei gleichen jährlichen Raten beginnend am 5. August 2026, vorbehaltlich fortgesetzter Dienstzeit.

Vested Phantom-Einheiten werden ausschließlich in bar abgewickelt, basierend auf dem Marktwert der entsprechenden Anzahl von Aktien bei Beendigung des Dienstverhältnisses, bei einem definierten Liquiditäts-Change-of-Control oder am siebten Jahrestag der Gewährung. Das Formular 4 berichtet nach der Transaktion über 18.800 wirtschaftlich gehaltene Aktien und ist am 05.09.2025 vom Bevollmächtigten Ryker Willie unterzeichnet.

Positive
  • Director alignment: Grant ties director compensation to company stock value through phantom units.
  • Retention incentive: Vesting in three equal annual installments beginning 08/05/2026 encourages continued service.
  • No immediate dilution: Phantom units are settled in cash, so common shares are not issued at grant.
Negative
  • None.

Insights

TL;DR Routine director compensation in phantom units; creates potential future cash obligation but no immediate equity dilution.

The grant of 18,800 phantom units to a director is a standard non-equity compensation mechanism that ties pay to the company's stock value without issuing shares today. Vesting over three years encourages retention. Because settlement is in cash, this creates a contingent cash liability timed to vesting, termination, change in control, or the 7th anniversary, rather than increasing share count.

TL;DR Governance-wise, the award aligns a director with shareholder outcomes while preserving current share capital structure.

The structure—phantom units with service-based vesting and cash settlement—aligns incentives without immediately diluting equity. Key governance points are the multi-year vesting schedule and defined settlement triggers including termination and change in control. The disclosure is clear on mechanics and timing.

Emil Chuang, amministratore di Palisade Bio, Inc. (PALI), ha ricevuto 18.800 unità fantasma il 04/09/2025. Ciascuna unità fantasma corrisponde a una azione ordinaria ed è stata assegnata a $0 per unità. Le unità maturano in tre rate annuali uguali a partire dal 5 agosto 2026, subordinatamente al proseguimento del servizio.

Le unità fantasma maturate saranno liquidate esclusivamente in contanti in base al valore di mercato delle azioni corrispondenti al momento della cessazione del servizio, di un determinato cambio di controllo con evento di liquidità, o al settimo anniversario della concessione. Il Modulo 4 riferisce 18.800 azioni possedute beneficiariamente a seguito della transazione ed è firmato dall’avvocato delegato Ryker Willie il 05/09/2025.

Emil Chuang, director de Palisade Bio, Inc. (PALI), recibió 18.800 unidades fantasma el 04/09/2025. Cada unidad fantasma equivale a una acción ordinaria y se concedieron a $0 por unidad. Las unidades consolidan en tres cuotas anuales iguales a partir del 5 de agosto de 2026, sujeto a la continuidad del servicio.

Las unidades fantasma consolidadas se liquidarán únicamente en efectivo según el valor razonable de mercado del mismo número de acciones al momento de la terminación del servicio, de un cambio de control con evento de liquidez definido, o del séptimo aniversario de la concesión. El Formulario 4 informa 18.800 acciones poseídas beneficiariamente tras la transacción y está firmado por el apoderado Ryker Willie el 05/09/2025.

파리지ë“� ë°”ì´ì˜�(Palisade Bio, Inc., PALI) ì´ì‚¬ Emil Chuangì—게 2025ë…� 9ì›� 4ì¼ì— 18,800ê°œì˜ íŒ¬í…€ 유닛ì� 부여ë˜ì—ˆìŠµë‹ˆë‹¤. ê°� 팬텀 ìœ ë‹›ì€ ë³´í†µì£� 1ì£¼ì— í•´ë‹¹í•˜ë©° 단가 $0ë¡� 부여ë˜ì—ˆìŠµë‹ˆë‹¤. 해당 ìœ ë‹›ì€ 2026ë…� 8ì›� 5ì¼ë¶€í„� 매년 ë™ì¼í•� 비율ë¡� 3íšŒì— ê±¸ì³ ë² ìŠ¤íŒ…ë˜ë©� ê³„ì† ê·¼ë¬´ë¥� 조건으로 합니ë‹�.

ë² ìŠ¤íŒ…ëœ íŒ¬í…€ ìœ ë‹›ì€ ê·¼ë¬´ 종료 ì‹�, ì •ì˜ë� 유ë™ì„� 있는 ì¸ìˆ˜í•©ë³‘(ì²´ì¸ì§€ì˜¤ë¸Œì»¨íЏë¡�) ë°œìƒ ì‹� ë˜ëŠ” 부여ì¼ë¡œë¶€í„� 7주년ì—� 해당하는 시ì ì—� ë™ë“±í•� 수량ì� 주ì‹ì� ê³µì •ì‹œìž¥ê°€ì¹˜ì— ë”°ë¼ í˜„ê¸ˆìœ¼ë¡œë§� ì •ì‚°ë©ë‹ˆë‹�. Form 4ì—는 거래 í›� 18,800ì£¼ì˜ ì‹¤ì§ˆ 소유가 ë³´ê³ ë˜ì–´ 있으ë©�, 2025ë…� 9ì›� 5ì� ëŒ€ë¦¬ì¸ Ryker Willieê°€ 서명했습니다.

Emil Chuang, administrateur de Palisade Bio, Inc. (PALI), s’est vu accorder 18 800 unités fantômes le 04/09/2025. Chaque unité fantôme équivaut à une action ordinaire et les unités ont été attribuées à 0 $ l’unité. Les unités acquièrent des droits en trois versements annuels égaux à partir du 5 août 2026, sous réserve de la poursuite du service.

Les unités fantômes acquises seront réglées uniquement en numéraire en fonction de la juste valeur marchande du nombre équivalent d’actions lors de la cessation de service, d’un changement de contrôle défini avec événement de liquidité, ou au septième anniversaire de l’octroi. Le formulaire 4 signale 18 800 actions détenues bénéficiairement suite à la transaction et est signé par le mandataire Ryker Willie le 05/09/2025.

Emil Chuang, Direktor von Palisade Bio, Inc. (PALI), erhielt am 04.09.2025 18.800 Phantom-Einheiten. Jede Phantom-Einheit entspricht einer Stammaktie und die Einheiten wurden zu $0 pro Einheit gewährt. Die Einheiten vesten in drei gleichen jährlichen Raten beginnend am 5. August 2026, vorbehaltlich fortgesetzter Dienstzeit.

Vested Phantom-Einheiten werden ausschließlich in bar abgewickelt, basierend auf dem Marktwert der entsprechenden Anzahl von Aktien bei Beendigung des Dienstverhältnisses, bei einem definierten Liquiditäts-Change-of-Control oder am siebten Jahrestag der Gewährung. Das Formular 4 berichtet nach der Transaktion über 18.800 wirtschaftlich gehaltene Aktien und ist am 05.09.2025 vom Bevollmächtigten Ryker Willie unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chuang Emil

(Last) (First) (Middle)
1902 WRIGHT PLACE, SUITE 200

(Street)
CARLSBAD, CA 92008

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PALISADE BIO, INC. [ PALI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Units (1) 09/04/2025 A 18,800 (2)(3) (2)(3) Common Stock 18,800 $0 18,800 D
Explanation of Responses:
1. Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock.
2. The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.
3. Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Ryker Willie, Attorney-in-Fact 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Emil Chuang report on Form 4 for PALI?

He reported a grant of 18,800 phantom units on 09/04/2025 with 18,800 shares beneficially owned following the transaction.

When do the phantom units vest?

The units vest in three equal annual installments beginning on August 5, 2026, subject to continuous service.

How are vested phantom units settled?

Vested units are settled solely in cash based on the fair market value of equivalent shares upon termination, a liquidity change in control, or the 7th anniversary of the grant.

Does this grant dilute PALI's outstanding shares?

No immediate dilution is reported because the phantom units are cash-settled rather than issued as common stock.

Who signed the Form 4 and when?

The Form 4 was signed by attorney-in-fact Ryker Willie on 09/05/2025.
Palisade Bio Inc

NASDAQ:PALI

PALI Rankings

PALI Latest News

PALI Latest SEC Filings

PALI Stock Data

5.90M
4.77M
0.24%
5.92%
6.72%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
CARLSBAD